Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

BACKGROUND: Gastric cancer (GC) is a heterogenous disease consisted of several subtypes with distinct molecular traits. The clinical implication of molecular classification has been limited especially in association with treatment efficacy of ramucirumab or various targeted agents. METHODS: We condu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Genome Med
Autori principali: Kim, Seung Tae, Sa, Jason K., Oh, Sung Yong, Kim, Kyung, Hong, Jung Yong, Kang, Won Ki, Kim, Kyoung-Mee, Lee, Jeeyun
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836461/
https://ncbi.nlm.nih.gov/pubmed/33494793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-021-00826-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi